オンボディインジェクター市場の成長と動向分析レポート

On-body Injectors Market Growth & Trends

The global on-body injectors market size is expected to reach USD 12.7 billion by 2030, registering a CAGR of 14.9% from 2024 to 2030, according to a new report by Grand View Research, Inc.

世界のオンボディインジェクター市場規模は、2030年までに127億米ドルに達すると予想されており、2024年から2030年までのCAGRは14.9%となる見込みです。

The on-body injectors increase patient adherence to medication by offering easy-to-use, less pain and enabling extended drug administration without frequent hospital visits. These advantages of on-body injectors are significantly increasing their popularity. Moreover, regions such as Asia Pacific, with developing healthcare infrastructure and rising adoption of advanced medical devices, offer huge opportunities for market growth over the forecast period.

On-body Injectors Market Report Scope

The increasing concerns over needle stick injuries and the need to increase the safety for both patients and healthcare professionals by eliminating risks associated with needle insertion, drug preparation, and covering & disposing of needles, coupled with the increasing prevalence of chronic diseases such as cancer are some of the factors expected to drive the market growth over the forecast period.

According to the WHO agency International Agency for Research on Cancer (IARC), around 20 million people were diagnosed with cancer, and around 9.7 million mortalities occurred due to cancer in 2022. Several cancers and other chronic disease treatments require frequent injections of medications over extended periods. On-body injectors offer a convenient and potentially less disruptive alternative for patients to receive these medications compared to traditional hospital visits or self-administered injections, which can significantly increase their demand over the forecast period.

On-body Injectors Market Report Highlights

• Based on the technology, the spring-based segment accounted for the largest revenue share of 40.89% in 2023 owing to their consistent pressure and speed, which ensures precise dosing

• Based on technology, the rotary pump segment is expected to grow at the fastest CAGR of 15.1% during the forecast period owing to the high control offered by them in dispensing medications, minimizing the risk of dosing errors and maximizing therapeutic efficacy

• Based on the application, the diabetes segment accounted for the largest revenue share in 2023 due to the high prevalence of type 2 diabetes, which requires frequent administration

• Based on the application, the autoimmune diseases segment is expected to grow at the fastest CAGR owing to the rising prevalence of chronic autoimmune conditions such as multiple sclerosis, rheumatoid arthritis, and Inflammatory Bowel Diseases (IBD)

• Based on the end use, the homecare segment accounted for the largest revenue share in 2023 owing to the growing preference for self-administration of medications for managing chronic conditions such as diabetes, autoimmune disorders, and cancer in homecare settings

• In 2023, North America dominated with a share of 33.17%, driven by the presence of key market players, an increasing shift toward home care, and better access to advanced on-body injectors

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope

1.1. Segment Definitions

1.1.1. Technology

1.1.2. Application

1.1.3. End Use

1.1.4. Regional scope

1.1.5. Estimates and forecasts timeline

1.2. Research Methodology

1.3. Information Procurement

1.3.1. Purchased database

1.3.2. GVR’s internal database

1.3.3. Secondary sources

1.3.4. Primary research

1.3.5. Details of primary research

1.3.5.1. Data for primary interviews in North America

1.3.5.2. Data for primary interviews in Europe

1.3.5.3. Data for primary interviews in Asia Pacific

1.3.5.4. Data for primary interviews in Latin America

1.3.5.5. Data for Primary interviews in MEA

1.4. Information or Data Analysis

1.4.1. Data analysis models

1.5. Market Formulation & Validation

1.6. Model Details

1.6.1. Commodity flow analysis (Model 1)

1.6.2. Approach 1: Commodity flow approach

1.6.3. Volume price analysis (Model 2)

1.6.4. Approach 2: Volume price analysis

1.7. List of Secondary Sources

1.8. List of Primary Sources

1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.2.1. Technology outlook

2.2.2. Application outlook

2.2.3. End Use outlook

2.2.4. Regional outlook

2.3. Competitive Insights

Chapter 3. On-body Injectors Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Related/ancillary market outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.1.1. Increasing prevalence of chronic diseases

3.2.1.2. Technological advancements

3.2.1.3. Patient preference and compliance

3.2.1.4. Increasing focus on home healthcare

3.2.1.5. Increasing concerns about needlestick injuries

3.2.2. Market Restraint Analysis

3.2.2.1. High cost compared to alternatives

3.3. On-body Injectors Market Analysis Tools

3.3.1. Industry Analysis – Porter’s

3.3.1.1. Bargaining power of suppliers

3.3.1.2. Bargaining power of buyers

3.3.1.3. Threat of substitutes

3.3.1.4. Threat of new entrants

3.3.1.5. Competitive rivalry

3.3.2. PESTEL Analysis

3.3.2.1. Political landscape

3.3.2.2. Economic landscape

3.3.2.3. Social landscape

3.3.2.4. Technological landscape

3.3.2.5. Environmental landscape

3.3.2.6. Legal landscape

Chapter 4. On-body Injectors Market: Technology Estimates & Trend Analysis

4.1. Segment Dashboard

4.2. On-body Injectors Market: Technology Movement Analysis

4.3. On-body Injectors Market by Technology Outlook (USD Million)

4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following

4.5. Spring-based

4.5.1. Spring-based Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

4.6. Motor-driven

4.6.1. Motor-driven Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

4.7. Rotary Pump

4.7.1. Rotary Pump Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

4.8. Expanding Battery

4.8.1. Expanding Battery Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

4.9. Other

4.9.1. Other Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

Chapter 5. On-body Injectors Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard

5.2. On-body Injectors Market: Application Movement Analysis

5.3. On-body Injectors Market by Application Outlook (USD Million)

5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following

5.5. Oncology

5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

5.6. Diabetes

5.6.1. Diabetes Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

5.7. Cardiovascular Disease

5.7.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

5.8. Autoimmune Disease

5.8.1. Autoimmune Disease Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

5.9. Others

5.9.1. Others Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

Chapter 6. On-body Injectors Market: End Use Estimates & Trend Analysis

6.1. Segment Dashboard

6.2. On-body Injectors Market: End Use Movement Analysis

6.3. On-body Injectors Market by End Use Outlook (USD Million)

6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following

6.5. Hospitals & Clinics

6.5.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

6.6. Home Care Settings

6.6.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

6.7. Others

6.7.1. Others Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

Chapter 7. On-body Injectors Market: Regional Estimates & Trend Analysis

7.1. Regional Dashboard

7.2. Regional On-body Injectors Market movement analysis

7.3. On-body Injectors Market: Regional Estimates & Trend Analysis by Technology, Application & End Use

7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following

7.5. North America

7.5.1. North America On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.5.2. U.S.

7.5.2.1. Key Country Dynamics

7.5.2.2. Competitive Scenario

7.5.2.3. Regulatory Framework

7.5.2.4. Reimbursement scenario

7.5.2.5. U.S. On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.5.3. Canada

7.5.3.1. Key Country Dynamics

7.5.3.2. Competitive Scenario

7.5.3.3. Regulatory Framework

7.5.3.4. Reimbursement scenario

7.5.3.5. Canada On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.5.4. Mexico

7.5.4.1. Key Country Dynamics

7.5.4.2. Competitive Scenario

7.5.4.3. Regulatory Framework

7.5.4.4. Reimbursement scenario

7.5.4.5. Mexico On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.6. Europe

7.6.1. Europe On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.6.2. UK

7.6.2.1. Key Country Dynamics

7.6.2.2. Competitive Scenario

7.6.2.3. Regulatory Framework

7.6.2.4. Reimbursement scenario

7.6.2.5. UK On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.6.3. Germany

7.6.3.1. Key Country Dynamics

7.6.3.2. Competitive Scenario

7.6.3.3. Regulatory Framework

7.6.3.4. Reimbursement scenario

7.6.3.5. Germany On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.6.4. France

7.6.4.1. Key Country Dynamics

7.6.4.2. Competitive Scenario

7.6.4.3. Regulatory Framework

7.6.4.4. Reimbursement scenario

7.6.4.5. France On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.6.5. Italy

7.6.5.1. Key Country Dynamics

7.6.5.2. Competitive Scenario

7.6.5.3. Regulatory Framework

7.6.5.4. Reimbursement scenario

7.6.5.5. Italy On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.6.6. Spain

7.6.6.1. Key Country Dynamics

7.6.6.2. Competitive Scenario

7.6.6.3. Regulatory Framework

7.6.6.4. Reimbursement scenario

7.6.6.5. Spain On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.6.7. Denmark

7.6.7.1. Key Country Dynamics

7.6.7.2. Competitive Scenario

7.6.7.3. Regulatory Framework

7.6.7.4. Reimbursement scenario

7.6.7.5. Denmark On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.6.8. Sweden

7.6.8.1. Key Country Dynamics

7.6.8.2. Competitive Scenario

7.6.8.3. Regulatory Framework

7.6.8.4. Reimbursement scenario

7.6.8.5. Sweden On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.6.9. Norway

7.6.9.1. Key Country Dynamics

7.6.9.2. Competitive Scenario

7.6.9.3. Regulatory Framework

7.6.9.4. Reimbursement scenario

7.6.9.5. Norway On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.7. Asia Pacific

7.7.1. Asia Pacific On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.7.2. Japan

7.7.2.1. Key Country Dynamics

7.7.2.2. Competitive Scenario

7.7.2.3. Regulatory Framework

7.7.2.4. Reimbursement scenario

7.7.2.5. Japan On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.7.3. China

7.7.3.1. Key Country Dynamics

7.7.3.2. Competitive Scenario

7.7.3.3. Regulatory Framework

7.7.3.4. Reimbursement scenario

7.7.3.5. China On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.7.4. India

7.7.4.1. Key Country Dynamics

7.7.4.2. Competitive Scenario

7.7.4.3. Regulatory Framework

7.7.4.4. Reimbursement scenario

7.7.4.5. India On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.7.5. South Korea

7.7.5.1. Key Country Dynamics

7.7.5.2. Competitive Scenario

7.7.5.3. Regulatory Framework

7.7.5.4. Reimbursement scenario

7.7.5.5. South Korea On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.7.6. Australia

7.7.6.1. Key Country Dynamics

7.7.6.2. Competitive Scenario

7.7.6.3. Regulatory Framework

7.7.6.4. Reimbursement scenario

7.7.6.5. Australia On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.7.7. Thailand

7.7.7.1. Key Country Dynamics

7.7.7.2. Competitive Scenario

7.7.7.3. Regulatory Framework

7.7.7.4. Reimbursement scenario

7.7.7.5. Thailand On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.8. Latin America

7.8.1. Latin America On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.8.2. Brazil

7.8.2.1. Key Country Dynamics

7.8.2.2. Competitive Scenario

7.8.2.3. Regulatory Framework

7.8.2.4. Reimbursement scenario

7.8.2.5. Brazil On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.8.3. Argentina

7.8.3.1. Key Country Dynamics

7.8.3.2. Competitive Scenario

7.8.3.3. Regulatory Framework

7.8.3.4. Reimbursement scenario

7.8.3.5. Argentina On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.9. Middle East & Africa

7.9.1. Middle East & Africa On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.9.2. South Africa

7.9.2.1. Key Country Dynamics

7.9.2.2. Competitive Scenario

7.9.2.3. Regulatory Framework

7.9.2.4. Reimbursement scenario

7.9.2.5. South Africa On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.9.3. Saudi Arabia

7.9.3.1. Key Country Dynamics

7.9.3.2. Competitive Scenario

7.9.3.3. Regulatory Framework

7.9.3.4. Reimbursement scenario

7.9.3.5. Saudi Arabia On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.9.4. UAE

7.9.4.1. Key Country Dynamics

7.9.4.2. Competitive Scenario

7.9.4.3. Regulatory Framework

7.9.4.4. Reimbursement scenario

7.9.4.5. UAE On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

7.9.5. Kuwait

7.9.5.1. Key Country Dynamics

7.9.5.2. Competitive Scenario

7.9.5.3. Regulatory Framework

7.9.5.4. Reimbursement scenario

7.9.5.5. Kuwait On-body Injectors Market Estimates and Forecasts, 2018 – 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Market Participant Categorization

8.2. Key Company Profiles

8.2.1. West Pharmaceutical Services, Inc.

8.2.1.1. Company overview

8.2.1.2. Financial performance

8.2.1.3. Product benchmarking

8.2.1.4. Strategic initiatives

8.2.2. BD

8.2.2.1. Company overview

8.2.2.2. Financial performance

8.2.2.3. Product benchmarking

8.2.2.4. Strategic initiatives

8.2.3. Stevanato Group

8.2.3.1. Company overview

8.2.3.2. Financial performance

8.2.3.3. Product benchmarking

8.2.3.4. Strategic initiatives

8.2.4. Enable Injections

8.2.4.1. Company overview

8.2.4.2. Financial performance

8.2.4.3. Product benchmarking

8.2.4.4. Strategic initiatives

8.2.5. Nemera

8.2.5.1. Company overview

8.2.5.2. Financial performance

8.2.5.3. Product benchmarking

8.2.5.4. Strategic initiatives

8.2.6. Debiotech SA

8.2.6.1. Company overview

8.2.6.2. Financial performance

8.2.6.3. Product benchmarking

8.2.6.4. Strategic initiatives

8.2.7. AbbVie, Inc.

8.2.7.1. Company overview

8.2.7.2. Financial performance

8.2.7.3. Product benchmarking

8.2.7.4. Strategic initiatives

8.2.8. Coherus BioSciences, Inc.

8.2.8.1. Company overview

8.2.8.2. Financial performance

8.2.8.3. Product benchmarking

8.2.8.4. Strategic initiatives

8.2.9. Gerresheimer AG

8.2.9.1. Company overview

8.2.9.2. Financial performance

8.2.9.3. Product benchmarking

8.2.9.4. Strategic initiatives

8.2.10. E3D Elcam Drug Delivery Devices

8.2.10.1. Company overview

8.2.10.2. Financial performance

8.2.10.3. Product benchmarking

8.2.10.4. Strategic initiatives

List of Tables

List of Tables

Table 1 List of Secondary Sources

Table 2 List of Abbreviations

Table 3 Global on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 4 Global on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 5 Global on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 6 North America on-body injectors market, by region, 2018 – 2030 (USD Million)

Table 7 North America on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 8 North America on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 9 North America on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 10 U.S. on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 11 U.S. on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 12 U.S. on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 13 Canada on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 14 Canada on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 15 Canada on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 16 Mexico on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 17 Mexico on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 18 Mexico on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 19 Europe on-body injectors market, by country, 2018 – 2030 (USD Million)

Table 20 Europe on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 21 Europe on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 22 Europe on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 23 UK on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 24 UK on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 25 UK on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 26 Germany on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 27 Germany on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 28 Germany on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 29 France on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 30 France on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 31 France on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 32 Italy on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 33 Italy on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 34 Italy on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 35 Spain on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 36 Spain on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 37 Spain on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 38 Norway on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 39 Norway on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 40 Norway on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 41 Sweden on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 42 Sweden on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 43 Sweden on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 44 Denmark on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 45 Denmark on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 46 Denmark on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 47 Asia Pacific on-body injectors market, by country, 2018 – 2030 (USD Million)

Table 48 Asia Pacific on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 49 Asia Pacific on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 50 Asia Pacific on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 51 Japan on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 52 Japan on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 53 Japan on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 54 China on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 55 China on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 56 China on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 57 India on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 58 India on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 59 India on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 60 Australia on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 61 Australia on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 62 Australia on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 63 South Korea on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 64 South Korea on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 65 South Korea on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 66 Thailand on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 67 Thailand on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 68 Thailand on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 69 Latin America on-body injectors market, by country, 2018 – 2030 (USD Million)

Table 70 Latin America on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 71 Latin America on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 72 Latin America on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 73 Brazil on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 74 Brazil on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 75 Brazil on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 76 Argentina on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 77 Argentina on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 78 Argentina on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 79 Middle East & Africa on-body injectors market, by country, 2018 – 2030 (USD Million)

Table 80 Middle East & Africa on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 81 Middle East & Africa on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 82 Middle East & Africa on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 83 South Africa on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 84 South Africa on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 85 South Africa on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 86 Saudi Arabia on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 87 Saudi Arabia on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 88 Saudi Arabia on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 89 UAE on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 90 UAE on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 91 UAE on-body injectors market, by end use, 2018 – 2030 (USD Million)

Table 92 Kuwait on-body injectors market, by technology, 2018 – 2030 (USD Million)

Table 93 Kuwait on-body injectors market, by application, 2018 – 2030 (USD Million)

Table 94 Kuwait on-body injectors market, by end use, 2018 – 2030 (USD Million)

List of Figures

List of Figures

Fig. 1 Information Procurement

Fig. 2 Primary Research Pattern

Fig. 3 Market Research Approaches

Fig. 4 Value Chain-Based Sizing & Forecasting

Fig. 5 Market Formulation & Validation

Fig. 6 On-body injectors market segmentation

Fig. 7 Market driver analysis (Current & future impact)

Fig. 8 Market restraint analysis (Current & future impact)

Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)

Fig. 10 Porter’s Five Forces Analysis

Fig. 11 On-body injectors market, technology outlook key takeaways (USD Million)

Fig. 12 On-body injectors market: Technology movement analysis (USD Million), 2023 & 2030

Fig. 13 Spring-based market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 14 Motor-driven market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 15 Rotary pump market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 16 Expanding battery market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 17 Other market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 18 On-body injectors market, application outlook key takeaways (USD Million)

Fig. 19 On-body injectors market: Application movement analysis (USD Million), 2023 & 2030

Fig. 20 Oncology market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 21 Diabetes market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 22 Cardiovascular disease market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 23 Autoimmune disease market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 24 Others market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 25 On-body injectors market, end use outlook key takeaways (USD Million)

Fig. 26 On-body injectors market: End use movement analysis (USD Million), 2023 & 2030

Fig. 27 Hospitals & clinics market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 28 Home care settings market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 29 Others market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 30 On-body injectors market: Regional key takeaways (USD Million)

Fig. 31 On-body injectors market: Regional outlook, 2023 & 2030, USD Million

Fig. 32 North America on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 33 U.S. on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 34 Canada on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 35 Mexico on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 36 Europe on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 37 UK on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 38 Germany on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 39 France on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 40 Spain on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 41 Italy on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 42 Sweden on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 43 Norway on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 44 Denmark on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 45 Asia Pacific on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 46 China on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 47 Japan on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 48 India on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 49 South Korea on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 50 Australia on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 51 Thailand on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 52 Latin America on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 53 Brazil on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 54 Argentina on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 55 Middle East and Africa on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 56 South Africa on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 57 Saudi Arabia on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 58 UAE on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 59 Kuwait on-body injectors market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 60 List of key emerging company’s/technology disruptors/innovators

Grand View Researchについて

Grand View Research（グランドビューリサーチ） はインドと米国を拠点とする市場調査およびコンサルティング会社です。世界中主要 25ヵ国・ 46 業界に関する豊富なデータベースを活用した市場情報は世界の企業団体に活用・引用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ 1

ライセンスタイプ 2

ライセンスタイプ 3

ライセンスタイプ 4

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス（インディビジュアルライセンス）
    • 1名のみレポートファイル（印刷不可）をご利用いただけます。
  • チームライセンス
    • 同一企業（関連会社除く）内5名まで共有可能です。印刷可能な電子ファイルをご提供いたします。
  • コーポレートライセンス
    • 同一企業および関連会社内で人数無制限で共有可能です。印刷可能な電子ファイルをご提供いたします。
    • 「関連会社」の範囲についてはお気軽にお問い合わせください。
• 納品形態
  • オンラインダウンロード
• 納期
  • ご注文後1～7営業日　※レポートにより異なります。

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

最新出版レポート

• ARクラウド市場規模、成長と動向分析レポート 2025-2033年
• ノーコードAIプラットフォーム市場規模、成長と動向分析レポート 2025-2033年
• 量子コンピューティングにおけるAI最適化市場規模、成長と動向分析レポート 2025-2033年
• ワイヤレス状態監視システム市場規模、成長と動向分析レポート 2025-2033年
• ゲームストリーミング市場規模、成長と動向分析レポート 2025-2033年

出版レポート一覧